Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carvativir versus placebo for COVID-19
ISRCTN15363958Phase 3Completed
- Sponsor
- Instituto Venezolano de Investigaciones Científicas
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing Carvativir treatment group with Placebo treatment group (2 arms). Primary endpoints: RT-PCR diagnosis of COVID-19 infection, Diagnosis of COVID-19 infection due to absence of acute respiratory infection at day 45 and 2 more. Started Jul 2020; status: completed.
02
Drugs
Carvativir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ISRCTN15363958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN15363958.